Innate Pharma SA files 6-K

Innate Pharma S.A. announced on May 22, 2026, that it has entered into a definitive agreement to sell its subsidiary, Innate Pharma Inc., to Sanofi S.A. for an upfront payment of $100 million, with potential additional payments of up to $400 million. This transaction is expected to close in the third quarter of 2026, subject to customary closing conditions.